Bcl-2 inhibitors (UCB)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameBcl-2 inhibitors (UCB)

Drug Alias NameUCB-1309149UCB-1350883UCB-1850833UCB-1353749

ClassificationSmall molecules

Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsApoptosis stimulants

TargetsApoptosis regulator Bcl-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUcb Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesUcb Sa

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A